case_images: PMC6580185_01
case_images: Liver function test values before, during, and after treatment with voriconazole. Day 1 refers to the first day of the first induction chemotherapy.
case_images: fphar-10-00645-g001.jpg
case_images: PMC6580185_01_fphar-10-00645-g001.jpg
case_images: f1
case_images: Ten days after starting voriconazole, however, her liver transaminases rose, accompanied by only slightly elevated cholestatic parameters and normal bilirubin levels ( Figure 1 ).
case_images: Liver function test values before, during, and after treatment with posaconazole. Day 1 refers to the first day of the second induction chemotherapy. Isavuconazole treatment was started on day 29.
case_images: fphar-10-00645-g002.jpg
case_images: PMC6580185_01_fphar-10-00645-g002.jpg
case_images: f2
case_images: After 4 days of posaconazole treatment, liver enzymes began to rise ( Figure 2 ). However, despite this, transaminases continued to rise ( Figure 2 ).
case_images: Isavuconazole treatment, chemotherapy, and allogenic HSCT (day 46). Day 1 refers to the first day of isavuconazole treatment.
case_images: fphar-10-00645-g003.jpg
case_images: PMC6580185_01_fphar-10-00645-g003.jpg
case_images: f3
case_images: During the first weeks of treatment with isavuconazole, transaminases steadily decreased, and the patient improved clinically ( Figure 3 ).